Psoriasis Care Guides
Unlock Radiant Skin: The Ultimate Guide to the ...
What to look for in a facial moisturizer for psoriasis, and how our Xpsoria Moisturizer fits a gentle daily routine.
Unlock Radiant Skin: The Ultimate Guide to the ...
What to look for in a facial moisturizer for psoriasis, and how our Xpsoria Moisturizer fits a gentle daily routine.
Soothe and Heal: DIY Skincare Recipes for Psori...
Gentle, non-abrasive DIY treatments for psoriasis, with a note on why physical scrubs are best avoided on active plaques.
Soothe and Heal: DIY Skincare Recipes for Psori...
Gentle, non-abrasive DIY treatments for psoriasis, with a note on why physical scrubs are best avoided on active plaques.
Showering with Psoriasis: A Soothing Routine fo...
A soothing shower routine for psoriasis, with real product recommendations and a note on avoiding scrubbing.
Showering with Psoriasis: A Soothing Routine fo...
A soothing shower routine for psoriasis, with real product recommendations and a note on avoiding scrubbing.
Navigating the Challenges of Anxiety and Psoria...
How anxiety and psoriasis reinforce each other, and a holistic approach combining real skincare products with emotional support strategies.
Navigating the Challenges of Anxiety and Psoria...
How anxiety and psoriasis reinforce each other, and a holistic approach combining real skincare products with emotional support strategies.
Probiotics for Psoriasis: What the Clinical Tri...
Multiple independent meta-analyses show probiotics significantly improve PASI scores - more consistent evidence than several other supplements.
Probiotics for Psoriasis: What the Clinical Tri...
Multiple independent meta-analyses show probiotics significantly improve PASI scores - more consistent evidence than several other supplements.
JAK Inhibitors: The Newest Class of Psoriasis T...
How TYK2 inhibitors like deucravacitinib work, the phase III trial data behind them, and why their safety profile differs from older options.
JAK Inhibitors: The Newest Class of Psoriasis T...
How TYK2 inhibitors like deucravacitinib work, the phase III trial data behind them, and why their safety profile differs from older options.